November 3, 2014 
Joaquín M. Espinosa - Howard Hughes Medical Institute and University of Colorado at Boulder
Taming the p53 network for therapeutic purposes

October 31, 2014 
Carla Taveggia - Group Leader of Axo-Glia Interaction Unit San Raffaele Scientific Institute, Milan, Italy
Novel players on the stage of myelination

October 24, 2014 
Stefano Indraccolo, M.D. - Group Leader, Istituto Oncologico Veneto - IRCCS, Padova, Italy
Metabolic effects of anti-VEGF therapy in tumors

October 2, 2014 
Heinrich G. Göttlinger, Program in Gene Function and Expression, and Program in Molecular Medicine, University of Massachusetts Medical School, MA, USA
Factors Involved in HIV Release and Infectivity

July 21, 2014 
Ernesto Guccione, Ph.D., Institute of Molecular and Cell Biology (IMCB) 61 Biopolis Drive, Singapore 
PRMT5: Learning From Development To Target Splicing In Cancer Therapy

June 23, 2014 
Daniel Menendez, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences (NIEHS), NIH (USA)
Integration of human immune and chromosomal stress responses by the p53 tumor suppressor

June 10, 2014 
John P. Fisher, Fischell Family Distinguished Professor, University of Maryland, College Park, MD
Bridging Stem Cell Technology with Tissue Vascularization in Regenerative Medicine

May 30, 2014 
Laura Caberlotto, The Microsoft Research - University of Trento Centre for Computational Systems Biology (COSBI)
Are Alzheimer’s disease and neurodegenerative dementia primarily metabolic diseases?

May 16, 2014 
Constance Ciaudo, Swiss Federal Institute of Technology Zurich, Department of Biology, Chair of RNAi and Genome Integrity, Zurich, Switzerland
miR-17-92 maintains cancer homeostasis by fine-tuning MYC and MYC-centered regulatory networks.

May 9, 2014 
Tiziana Bonaldi, Department of Experimental Oncology, European Institute of Oncology, Milan, Italy
miR-17-92 maintains cancer homeostasis by fine-tuning MYC and MYC-centered regulatory networks.

April 11, 2014 
Valentina Bonetto, Laboratory of Translational Proteomics, Mario Negri Institute Milan, Italy
Cyclophilin A governs TDP-43 function and assembly in hnRNP complexes: implications for TDP-43 pathology.

April 3, 2014 
Luca Magnani, Dept. of Surgery and Cancer, Imperial College, Hammersmith Hospital, London
Targeted therapy in the epigenomics era: hopes and opportunities.

March 31, 2014 
Mauro Giacca, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy
Why can't HIV-1 infection be eradicated?

March 7, 2014 
Gaetano Finocchiaro, Unit of Molecular Neuro-Oncology, Besta Neurological Institute, IRCCS, Milan, Italy
Glioblastoma: genomic landscapes and novel treatments

February 12, 2014 
Stefano Ciurli, General and Inorganic Chemistry, University of Bologna, Italy 
The chemistry of nickel in the urease system 

January 21, 2014 
Marco Garavelli, Laboratory of Chemistry, Ecole Normale Supérieure of Lyon, France  
Towards an Accurate Computational Photobiology